Perceptions of vaccination certificates among the general population in Geneva, Switzerland.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
22 11 2021
Historique:
entrez: 30 11 2021
pubmed: 1 12 2021
medline: 15 12 2021
Statut: epublish

Résumé

This study aimed to assess the public perception of COVID-19 vaccination certificates as well as potential differences between individuals. Between 17 March and 1 April 2021, a self-administered online questionnaire was proposed to all persons aged 18 years and older participating in the longitudinal follow-up of SARS-CoV-2 seroprevalence studies in Geneva, Switzerland. The questionnaire covered aspects of individual and collective benefits, and allowed participants to select contexts in which vaccination certificates should be presented. Results were presented as the proportion of persons agreeing or disagreeing with the implementation of vaccination certificates, selecting specific contexts where certificates should be presented, and agreeing or disagreeing with the potential risks related to certificates. Logistic regression was used to calculate odds ratios for factors associated with certificate non-acceptance. Overall, 4067 individuals completed the questionnaire (response rate 77.4%; mean age 53.3 ± standard deviation 14.4 years; 56.1% were women). About 61.0% of participants agreed or strongly agreed that a vaccination certificate was necessary in certain contexts and 21.6% believed there was no context where vaccination certificates should be presented. Contexts where a majority of participants perceived a vaccination certificate should be presented included jobs where others would be at risk of COVID-related complications (60.7%), jobs where employees would be at risk of getting infected (58.7%), or to be exempt from quarantine when travelling abroad (56.0%). Contexts where fewer individuals perceived the need for vaccination certificates to be presented were participation in large gatherings (36.9%), access to social venues (35.5%), or sharing the same workspace (21.5%). Younger age, no intent for vaccination, and not believing vaccination to be an important step in surmounting the pandemic were factors associated with certificate non-acceptance. This large population-based study showed that the general adult population in Geneva, Switzerland, agreed with the implementation of vaccination certificates in work-related and travel-related contexts. However, this solution was perceived as unnecessary for access to large gatherings or social venues, or to share the same workspace. Differences were seen with age, sex, education, socioeconomic status, and vaccination willingness and perception, highlighting the importance of taking personal and sociodemographic variation into consideration when predicting acceptance of such certificates.

Identifiants

pubmed: 34846113
doi: 10.4414/smw.2021.w30079
pii: Swiss Med Wkly. 2021;151:w30079
doi:
pii:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

w30079

Auteurs

Mayssam Nehme (M)

Division and Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.

Helene Baysson (H)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.

Nick Pullen (N)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.

Ania Wisniak (A)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
Institute of Global Health, Faculty of Medicine, University of Geneva, Switzerland.

Francesco Pennacchio (F)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.

María-Eugenia Zaballa (ME)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.

Vanessa Fargnoli (V)

Institute of sociological research, University of Geneva, Switzerland.

Laurent Kaiser (L)

Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.
Department of Medicine, Faculty of Medicine, University of Geneva, Switzerland.
Geneva Centre for Emerging Viral Diseases and Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland.

Samia Hurst (S)

Institute for ethics, history and the humanities, Faculty of Medicine, University of Geneva, Switzerland.

Claudine Burton-Jeangros (C)

Institute of sociological research, University of Geneva, Switzerland.

Silvia Stringhini (S)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Switzerland.
University Center for General Medicine and Public Health, University of Lausanne, Switzerland.

Idris Guessous (I)

Division and Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH